News
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
Now, a simple blood test could finally offer families like hers the clarity they’ve long needed.The US Food and Drug ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can be used to detect amyloid plaques ...
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results